dsip-safety-data DSIP DSIP Peptide – Sleep Regulation

Key gaps include: No large-scale randomised controlled trials in humans the evidence basis for clinical use is extrapolated from animal data and small pilot studies No long-term safety data effects beyond 1216 weeks are not well characterised Variable results in human sleep trials some early human studies showed modest or inconsistent effects on sleep architecture compared to animal data, suggesting the translation may not be linear No FDA approval DSIP is not approved for any therapeutic use in the United States Stability concerns DSIP degrades relatively quickly in circulation

10.1038/s41598-017-15028-x 106

Watermann I, Schmitt B, Stellmacher F, Mller J, Gaber R, Kugler C, et al

It has been shown to heal periodontitis in mice

How Epithalon (10mg) Supports Research In laboratory settings, Epithalon is used as a research tool peptide in studies that investigate cellular aging mechanisms and telomere-associated biology